Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FJQ99
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,586
Award facts
- Contract value 100% obligated
- $38,586.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,586.44 to AmerisourceBergen Drug Corp for XGEVA 120 mg/1.7 ml vials on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. XGEVA is a specialty pharmaceutical product used in oncology and bone health treatment, reflecting the contractor's role as a critical vendor for federal medical procurement needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains an extensive portfolio of federal medical supply contracts demonstrating its capability to meet diverse federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJQ99?
SPE2DB25FJQ99 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FJQ99 worth?
The government has obligated $38,586 on SPE2DB25FJQ99.
Is contract SPE2DB25FJQ99 an order under another contract?
Yes. SPE2DB25FJQ99 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJQ99 competed?
The extent of competition for SPE2DB25FJQ99 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award